| Identification | Back Directory | [Name]
N6-Ethyl-2’-O-methyladenosine | [CAS]
157309-11-0 | [Synonyms]
N6-Ethyl-2’-O-methyladenosine
Adenosine, N-ethyl-2'-O-methyl- (9CI) | [Molecular Formula]
C13H19N5O4 | [MOL File]
157309-11-0.mol | [Molecular Weight]
309.32 |
| Hazard Information | Back Directory | [Uses]
N6-Ethyl-2’-O-methyladenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500. DOI:10.1016/j.drudis.2021.02.020
[2] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|